Biotech

All Articles

Tracon winds down weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has decided to wind down operations full weeks after an injectable immune ch...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on neglected epilepsy medicine, proclaims FDA manage

.Our company currently recognize that Takeda is actually hoping to find a path to the FDA for epilep...

VBI Injections files for insolvency, looks for asset sale

.Immunology biotech VBI Injections is actually diverting precariously close to the moment of truth, ...

Celldex anti-cKIT antibody lower hives in another period 2 research study

.It's challenging to muscle mass in on a space as affordable as immunology, yet Celldex Rehabs feels...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies as well as a preclinical immu...

Ventyx's last resort for inflamed med ends in Crohn's failure

.Ventyx Biosciences' Crohn's health condition medicine performed not aid people achieve remission in...

Cognition's period 2 radiate information stain Alzheimer's prospect

.Cognition Therapeutics' stage 2 luster test has actually taken a few of the gloss off the Alzheimer...

BMS axes bispecific months after filing to operate stage 3 test

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., that supervised Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers S...